- Research Grants
Raquel Bester Liszbinski in research grants and scholarships supported by FAPESP.
Breast Cancer is the second most common Cancer in incidence and mortality among females and according to national and international health organizations, this number has increased in recent years. The development of new therapies for the treatment of Cancer is necessary because of this increasing number of cases and the difficulty of effective treatments. Among the molecular mechanisms ...
Colorectal cancer (CRC) is the third most prevalent type of cancer worldwide and frequently associated with metastatic complications. Therapeutic strategies used to treat those patients who do not respond to conventional chemotherapy is based on the application of monoclonal antibodies cetuximab or panitumumab, both directed to the epidermal growth factor receptor (EGFR). However, in so...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
(References retrieved automatically from State of São Paulo Research Institutions)
LISZBINSKI, Raquel Bester. Transporte de 5-fluorouracil por nanopartículas de ouro funcionalizados com anticorpos contra receptores de fatores de crescimento epidérmico (EGFR e HER2). Dissertação (Mestrado) - Universidade Estadual Paulista "Júlio de Mesquita Filho" Instituto de Biociências (Campus de Botucatu). (15/26729-2)